Home » Analyst Articles – US
Amazon.com (AMZN) PT Raised to $1,750.00
Amazon.com (NASDAQ:AMZN) had its target price boosted by investment analysts at Wedbush to $1,750.00 in a research note issued on Friday, The Fly reports. The firm currently has an “outperform” rating on the e-commerce... More of this article »
ABIOMED (ABMD) Price Target Raised to $259.00 at Morgan Stanley
ABIOMED (NASDAQ:ABMD) had its target price hoisted by equities research analysts at Morgan Stanley from $204.00 to $259.00 in a research note issued to investors on Friday. The brokerage currently has an “equal weight”... More of this article »
Akamai Technologies (AKAM) Price Target Raised to $60.00 at Nomura
Akamai Technologies (NASDAQ:AKAM) had its price target hoisted by equities research analysts at Nomura from $50.00 to $60.00 in a research note issued to investors on Friday. The firm presently has a “neutral” rating on... More of this article »
Amgen (AMGN) Price Target Cut to $196.00
Amgen (NASDAQ:AMGN) had its price target reduced by equities research analysts at Morgan Stanley from $204.00 to $196.00 in a research report issued on Friday. The firm presently has an “overweight” rating on the medical... More of this article »
Amgen (AMGN) Price Target Increased to $202.00 by Analysts at BMO Capital Markets
Amgen (NASDAQ:AMGN) had its target price hoisted by stock analysts at BMO Capital Markets from $192.00 to $202.00 in a research note issued on Friday. The brokerage currently has a “market perform” rating on the medical... More of this article »
AbbVie (ABBV) Price Target Raised to $145.00
AbbVie (NYSE:ABBV) had its price target lifted by equities researchers at Argus from $120.00 to $145.00 in a research report issued on Friday. The brokerage currently has a “buy” rating on the stock. Argus’ price... More of this article »
AMETEK (AME) Price Target Raised to $90.00
AMETEK (NYSE:AME) had its target price increased by research analysts at BMO Capital Markets from $88.00 to $90.00 in a research note issued on Friday. The firm currently has an “outperform” rating on the technology company’s... More of this article »
Amgen (AMGN) PT Lowered to $190.00
Amgen (NASDAQ:AMGN) had its target price lowered by analysts at Piper Jaffray Companies from $194.00 to $190.00 in a report released on Friday. The brokerage currently has an “overweight” rating on the medical research... More of this article »
Aptiv (APTV) PT Raised to $108.00
Aptiv (NYSE:APTV) had its price target upped by analysts at Piper Jaffray Companies from $105.00 to $108.00 in a research report issued on Friday. The firm presently has an “overweight” rating on the auto parts company’s... More of this article »
Bank of America (BAC) Price Target Raised to $37.00
Bank of America (NYSE:BAC) had its price objective upped by analysts at Morgan Stanley from $35.00 to $37.00 in a research note issued on Friday. The brokerage currently has an “overweight” rating on the financial services... More of this article »
Barclays Increases Aptiv (APTV) Price Target to $114.00
Aptiv (NYSE:APTV) had its target price raised by research analysts at Barclays from $104.00 to $114.00 in a note issued to investors on Friday. The brokerage presently has an “overweight” rating on the auto parts company’s... More of this article »
American Express (AXP) Given New $109.00 Price Target at Morgan Stanley
American Express (NYSE:AXP) had its price objective raised by equities research analysts at Morgan Stanley from $108.00 to $109.00 in a research report issued to clients and investors on Friday. The brokerage currently has an “equal... More of this article »
Morgan Stanley Boosts C.H. Robinson Worldwide (CHRW) Price Target to $70.00
C.H. Robinson Worldwide (NASDAQ:CHRW) had its price target hoisted by investment analysts at Morgan Stanley from $57.00 to $70.00 in a report released on Friday. The brokerage currently has an “underweight” rating on the... More of this article »
Carnival (CCL) Price Target Raised to $70.00 at Morgan Stanley
Carnival (NYSE:CCL) had its price target lifted by analysts at Morgan Stanley from $68.00 to $70.00 in a research note issued on Friday. The brokerage presently has an “equal weight” rating on the stock. Morgan Stanley’s... More of this article »
Morgan Stanley Raises Citigroup (C) Price Target to $92.00
Citigroup (NYSE:C) had its price target hoisted by Morgan Stanley from $88.00 to $92.00 in a note issued to investors on Friday. The brokerage currently has an “overweight” rating on the financial services provider’s... More of this article »
Bank of New York Mellon (BK) PT Raised to $65.00
Bank of New York Mellon (NYSE:BK) had its price target lifted by analysts at Morgan Stanley from $64.00 to $65.00 in a report issued on Friday. The firm presently has an “overweight” rating on the bank’s stock. Morgan... More of this article »
Morgan Stanley Raises BB&T (BBT) Price Target to $59.00
BB&T (NYSE:BBT) had its price objective upped by analysts at Morgan Stanley from $58.00 to $59.00 in a research report issued to clients and investors on Friday. The brokerage currently has an “equal weight” rating... More of this article »
Barclays Boosts Baxter International (BAX) Price Target to $77.00
Baxter International (NYSE:BAX) had its price objective upped by research analysts at Barclays from $73.00 to $77.00 in a report issued on Friday. The firm currently has an “overweight” rating on the medical instruments... More of this article »
BMO Capital Markets Raises Baxter International (BAX) Price Target to $77.00
Baxter International (NYSE:BAX) had its price target lifted by investment analysts at BMO Capital Markets from $74.00 to $77.00 in a report released on Friday. The firm presently has an “outperform” rating on the medical... More of this article »
CME Group (CME) Given New $175.00 Price Target at Barclays
CME Group (NASDAQ:CME) had its price target increased by Barclays from $170.00 to $175.00 in a research report issued on Friday. The brokerage presently has an “overweight” rating on the financial services provider’s... More of this article »
Barclays Boosts Edwards Lifesciences (EW) Price Target to $155.00
Edwards Lifesciences (NYSE:EW) had its target price raised by Barclays from $135.00 to $155.00 in a report issued on Friday. The brokerage presently has an “overweight” rating on the medical research company’s stock.... More of this article »
ConocoPhillips (COP) Price Target Raised to $72.00 at Barclays
ConocoPhillips (NYSE:COP) had its price target hoisted by analysts at Barclays from $59.00 to $72.00 in a research note issued on Friday. The firm currently has an “overweight” rating on the energy producer’s stock.... More of this article »
Edwards Lifesciences (EW) Price Target Raised to $138.00
Edwards Lifesciences (NYSE:EW) had its price target boosted by investment analysts at Morgan Stanley from $130.00 to $138.00 in a research report issued to clients and investors on Friday. The firm currently has an “overweight”... More of this article »